Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,924 | 113 | 99.5% |
| Education | $10.52 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $307.36 | 21 | $0 (2021) |
| PFIZER INC. | $236.12 | 14 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $166.12 | 10 | $0 (2021) |
| Merck Sharp & Dohme LLC | $157.55 | 10 | $0 (2023) |
| AbbVie Inc. | $136.74 | 7 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $96.68 | 6 | $0 (2024) |
| Lilly USA, LLC | $92.96 | 5 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $89.34 | 5 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $88.40 | 5 | $0 (2021) |
| Astellas Pharma US Inc | $77.92 | 4 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $76.45 | 3 | Novartis Pharmaceuticals Corporation ($27.22) |
| 2023 | $14.25 | 1 | Merck Sharp & Dohme LLC ($14.25) |
| 2022 | $17.03 | 1 | PFIZER INC. ($17.03) |
| 2021 | $538.10 | 30 | AbbVie Inc. ($136.74) |
| 2020 | $391.82 | 21 | GlaxoSmithKline, LLC. ($77.39) |
| 2019 | $284.28 | 16 | ASD SPECIALTY HEALTHCARE, LLC ($49.79) |
| 2018 | $179.14 | 12 | Novo Nordisk Inc ($46.72) |
| 2017 | $433.69 | 30 | GlaxoSmithKline, LLC. ($129.25) |
All Payment Transactions
114 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/04/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $27.22 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/06/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $25.08 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/02/2024 | Abbott Laboratories | ESPRIT (Device) | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: Vascular | ||||||
| 09/13/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug), RECARBRIO, ZERBAXA | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 02/25/2022 | PFIZER INC. | PREVNAR 20 (Biological) | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: VACCINES | ||||||
| 11/01/2021 | PFIZER INC. | PREVNAR 13 (Biological), PREVNAR 20 | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: VACCINES | ||||||
| 10/19/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.41 | General |
| Category: NEUROSCIENCE | ||||||
| 09/20/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.94 | General |
| Category: NEUROSCIENCE | ||||||
| 09/14/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/08/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: RESPIRATORY | ||||||
| 09/07/2021 | Axonics, Inc. | Axonics r-SNM System (Device) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: Urology | ||||||
| 08/23/2021 | PFIZER INC. | PREVNAR 13 (Biological), PREVNAR 20 | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: VACCINES | ||||||
| 08/09/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: NEUROSCIENCE | ||||||
| 08/03/2021 | PFIZER INC. | ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/22/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: Cardiovascular | ||||||
| 07/13/2021 | AbbVie Inc. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $22.16 | General |
| Category: IMMUNOLOGY | ||||||
| 07/13/2021 | AbbVie Inc. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $0.42 | General |
| Category: IMMUNOLOGY | ||||||
| 06/11/2021 | ARBOR PHARMACEUTICALS, INC. | Edarbyclor (Drug) | Food and Beverage | In-kind items and services | $12.89 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/08/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.84 | General |
| Category: NEUROSCIENCE | ||||||
| 06/03/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/18/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.22 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/12/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: Diabetes | ||||||
| 05/05/2021 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: UROLOGY | ||||||
| 05/04/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.19 | General |
| Category: NEUROSCIENCE | ||||||
| 04/29/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), ANORO ELLIPTA | Food and Beverage | In-kind items and services | $27.29 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 407 | 732 | $434,957 | $54,629 |
| 2022 | 8 | 768 | 1,468 | $921,105 | $119,612 |
| 2021 | 13 | 589 | 925 | $231,058 | $68,954 |
| 2020 | 21 | 762 | 1,192 | $182,046 | $67,672 |
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 139 | 383 | $269,394 | $33,751 | 12.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 105 | 185 | $78,424 | $10,523 | 13.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 134 | 135 | $65,676 | $7,897 | 12.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 14 | 14 | $9,276 | $1,233 | 13.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 15 | 15 | $12,187 | $1,226 | 10.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 336 | 988 | $618,116 | $79,813 | 12.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 72 | 73 | $82,551 | $11,714 | 14.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 124 | 126 | $87,106 | $10,431 | 12.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 74 | 111 | $45,144 | $6,142 | 13.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 97 | 98 | $38,290 | $5,473 | 14.3% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 20 | 20 | $20,377 | $2,737 | 13.4% |
| 99226 | Follow-up observation care per day, typically 35 minutes | Facility | 2022 | 16 | 23 | $15,773 | $1,756 | 11.1% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 29 | 29 | $13,749 | $1,546 | 11.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 176 | 348 | $57,420 | $28,546 | 49.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 69 | 69 | $10,350 | $9,092 | 87.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 54 | 96 | $46,443 | $8,115 | 17.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 49 | 108 | $53,079 | $6,238 | 11.8% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2021 | 18 | 24 | $8,400 | $5,218 | 62.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 28 | 29 | $26,668 | $4,780 | 17.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 42 | 51 | $5,610 | $3,005 | 53.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 39 | 39 | $17,806 | $2,261 | 12.7% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 21 | 56 | $2,520 | $547.82 | 21.7% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 24 | 24 | $648.00 | $438.00 | 67.6% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 36 | 39 | $1,170 | $378.69 | 32.4% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2021 | 15 | 15 | $405.00 | $273.75 | 67.6% |
About Dr. Alejandro Victoria, MD
Dr. Alejandro Victoria, MD is a Internal Medicine healthcare provider based in Clermont, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/24/2005. The National Provider Identifier (NPI) number assigned to this provider is 1043200934.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alejandro Victoria, MD has received a total of $1,935 in payments from pharmaceutical and medical device companies, with $76.45 received in 2024. These payments were reported across 114 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($1,924).
As a Medicare-enrolled provider, Victoria has provided services to 2,526 Medicare beneficiaries, totaling 4,317 services with total Medicare billing of $310,867. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Clermont, FL
- Active Since 10/24/2005
- Last Updated 03/11/2015
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1043200934
Products in Payments
- TRELEGY ELLIPTA (Drug) $129.88
- VRAYLAR (Drug) $110.60
- INVOKANA (Drug) $103.83
- ENTRESTO (Drug) $96.68
- CHANTIX (Drug) $87.29
- JANUVIA (Drug) $76.18
- EMGALITY (Drug) $75.39
- XARELTO (Drug) $62.29
- MYRBETRIQ (Drug) $58.56
- SHINGRIX (Biological) $48.23
- PREVNAR - 13 (Biological) $44.97
- Horizant (Drug) $42.85
- ADVAIR (Drug) $37.50
- ANORO (Drug) $36.80
- PREVNAR 13 (Biological) $36.21
- FARXIGA (Drug) $36.05
- SOLIQUA (Drug) $35.32
- TOUJEO (Drug) $34.85
- VIAGRA (Drug) $33.15
- Victoza (Drug) $33.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Clermont
Sumith Aleti, Md, MD
Internal Medicine — Payments: $29,143
Alexander Bolanos, M.d, M.D
Internal Medicine — Payments: $15,769
Nathan Bibliowicz, Do, DO
Internal Medicine — Payments: $14,320
Dr. Shazia Nasir, Md, MD
Internal Medicine — Payments: $11,207
Carolina Mejia Otero, M.d, M.D
Internal Medicine — Payments: $7,926
Dr. Kiran Mogali, M.d, M.D
Internal Medicine — Payments: $7,620